skip to content


Sun protection, actinic keratosis, AVENE SunsiStick KA SPF 50+

PIERRE FABRE DERMO KOSMETIK GmbH

Sale price £39.90 Regular price £50.00

Tax included. Shipping calculated at checkout.

AVENE SunsiStick KA SPF 50+, Sun protection, actinic keratosis

pack size:20g Dosage form:pencils

Very high daily sun protection, tailored to the needs of sensitive skin prone to actinic keratosis.

Localized areas: forehead, nose, cheekbones, scalp, back of the hands, etc.

The heart of SunsiStick KA SPF 50+ is a unique complex of active ingredients that comes from Pierre Fabre Sun protection, actinic keratosis, AVENE SunsiStick KA SPF 50+ research:

1. A stable and effective long-lasting filter system for a very broad UVB-UVA protection.
2. A duo of complementary antioxidants: Thialdine for immediate cell protection + Pro-Tocopherol® for comprehensive cell protection against oxidative stress.
3. Vederine™, an active ingredient that increases the synthesis of vitamin D receptors and strengthens the skin barrier.

Thanks to its smooth texture and stick shape, SunsiStick SPF KA 50+ is very easy to apply and use, even on the most sensitive areas of the skin.

SunsiStick KA SPF 50+ is perfectly tailored to the needs of high-risk skin that tends to actinic keratoses.



Sun protection, actinic keratosis, AVENE SunsiStick KA SPF 50+ Composition:


OCTYLDODECANOL. POLYETHYLENE. BUTYLENE GLYCOL COCOATE. HYDROGENATED MICROCRYSTALLINE WAX. BIS-ETHYLHEXYLOXYPHENOL METHOXYPHENYL TRIAZINE. DIETHYLAMINO HYDROXYBENZOYL HEXYL BENZOATE. DIETHYLHEXYL BUTAMIDO TRIAZONE. BUTYL METHOXYDIBENZOYLMETHANE. ETHYLHEXYL SALICYLATE. BEESWAX (CERA ALBA). HYDROGENATED CASTOR OIL. WATER (AQUA). 1,2-HEXANEDIOL. ALUMINUM HYDROXIDES. BUTYLENE GLYCOL. CAPRYLIC/CAPRIC TRIGLYCERIDES. CAPRYLYL GLYCOL. CICHORIUM INTYBUS (CHICORY) ROOT EXTRACT. DISODIUM STEAROYL GLUTAMATE. METHYL METHACRYLATE CROSSPOLYMER. OXOTHIAZOLIDINES. SACCHARIN. SODIUM BENZOATES. TITANIUM DIOXIDE (CI 77891). TOCOPHERYL GLUCOSIDES.

A notice:
Our INCI declaration given here corresponds to our current production status. Since we regularly incorporate new scientific findings into our formulations, it is possible that pharmacies may still have previous product versions with different declarations of ingredients.